Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of HCV in patients with severe liver disease: interim results of a compassionate use program

被引：0

作者：

Welzel, T. ^{[1
]}

Herzer, K. ^{[2
]}

Ferenci, P. ^{[3
]}

Petersen, J. ^{[4
]}

Gschwantler, M. ^{[5
]}

Cornberg, M. ^{[6
]}

Berg, T. ^{[7
]}

Spengler, U. ^{[8
]}

Weiland, O. ^{[9
]}

Van der Valk, M. ^{[10
]}

Klinker, H. ^{[11
]}

Rockstroh, J. ^{[8
]}

Ingiliz, P. ^{[9
]}

Peck-Radosavljevic, M. ^{[3
]}

Jimenez-Exposito, M. J. ^{[12
]}

Zeuzem, S. ^{[1
]}

机构：

[1] Goethe Univ Frankfurt, Univ Klinikum, D-60054 Frankfurt, Germany

[2] Univ Klinikum Essen AoR, Essen, Germany

[3] Med Univ Wien, Vienna, Austria

[4] IFI Inst Interdisziplinare Med, Hamburg, Germany

[5] Wilhelminenspital Stadt Wien, Vienna, Austria

[6] Hannover Med Sch, D-30623 Hannover, Germany

[7] Univ Klinikum Leipzig, Leipzig, Germany

[8] Univ Klinikum Bonn, Bonn, Germany

[9] Karolinska Inst, Solna, Sweden

[10] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands

[11] Univ Klinikum Wurzburg, Wurzburg, Germany

[12] Bristol Myers Squibb Co, Paris, France

来源：

JOURNAL OF VIRAL HEPATITIS | 2015年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

O123

引用

页码：4 / 5

页数：2

共 50 条

[1] DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN FOR THE TREATMENT OF HCV IN PATIENTS WITH SEVERE LIVER DISEASE: INTERIM RESULTS OF A MULTICENTER COMPASSIONATE USE PROGRAM
Welzel, T. M.
Herzer, K.
Ferenci, P.
Petersen, J.
Gschwantler, M.
Cornberg, M.
Berg, T.
Spengler, U.
Weiland, O.
Van der Valk, M.
Klinker, H.
Rockstroh, J.
Ingiliz, P.
Peck-Radosavljevic, M.
Jimenez-Exposito, M. J.
Zeuzem, S.
[J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S619 - S620
[2] Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of chronic HCV in patients coinfected with HIV: Interim results of a multicenter compassionate use program
Rockstroh, Juergen K.
Welzel, Tania M.
Ingiliz, Patrick
Petersen, Joerg
van der Valk, Marc
Herzer, Kerstin
Ferenci, Peter
Gschwantler, Michael
Cornberg, Markus
Berg, Thomas
Spengler, Ulrich
Weiland, Ola
Klinker, Hartwig
Peck-Radosavljevic, Markus
Zhao, Yue
Exposito, Maria Jesus Jimenez
Zeuzem, Stefan
[J]. HEPATOLOGY, 2015, 62 : 728A - 729A
[3] DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN FOR TREATMENT OF CHRONIC HCV INFECTION IN PATIENTS WITH ADVANCED LIVER DISEASE: RESULTS OF A EUROPEAN COMPASSIONATE USE PROGRAM
Welzel, T.
Petersen, J.
Herzer, K.
Ferenci, P.
Gschwantler, M.
Cornberg, M.
Ingiliz, P.
Berg, T.
Spengler, U.
Weiland, O.
van der Valk, M.
Klinker, H.
Rockstroh, J.
Peck-Radosavljevic, M.
Zhao, Y.
Jimenez-Exposito, M. J.
Zeuzem, S.
[J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S825 - S825
[4] Daclatasvir plus sofosbuvir with or without ribavirin in patients with chronic HCV infection: interim analysis of a multicenter compassionate use program
Welzel, T.
Cornberg, M.
Petersen, J.
Herzer, K.
Berg, T.
Spengler, U.
Rockstroh, J.
Ingiliz, P.
Wiegand, J.
Jimenez-Exposito, M.
Zeuzem, S.
[J]. JOURNAL OF VIRAL HEPATITIS, 2014, 21 : 24 - 25
[5] Daclatasvir plus Sofosbuvir ± Ribavirin in Liver Transplant Recipients with HCV Recurrence: Interim Results of a European Multicenter Compassionate Use Program
Herzer, Kerstin
Welzel, Tania
Ferenci, Peter
Petersen, Joerg
Gschwantler, Michael
Cornberg, Markus
Berg, Thomas
Spengler, Ulrich
Weiland, Ola
Van der Valk, Marc
Klinker, Hartwig
Rockstroh, Juergen
Schott, Eckart
Peck-Radosavljevic, Markus
Zhao, Yue
Exposito, Maria-Jesus Jimenez
Zeuzem, Stefan
[J]. TRANSPLANTATION, 2016, 100 : S181 - S181
[6] DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 3 INFECTION: INTERIM ANALYSIS OF A FRENCH MULTICENTER COMPASSIONATE USE PROGRAM
Hezode, C.
De Ledinghen, V.
Fontaine, H.
Zoulim, F.
Lebray, P.
Boyer, N.
Larrey, D.
Silvain, C.
Botta-Fridlund, D.
Leroy, V.
Bourliere, M.
D'Alteroche, L.
Hubert-Fouchard, I.
Guyader, D.
Rosa, I.
Nguyen-Khac, E.
Di Martino, V.
Carrat, F.
Fedchuk, L.
Akremi, R.
Bennai, Y.
Bronowicki, J. -P.
[J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S265 - S266
[7] Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV genotype 3 infection: interim analysis of a French multicenter compassionate use program
Hezode, C.
De Ledinghen, V.
Fontaine, H.
Zoulim, F.
Lebray, P.
Boyer, N.
Dominique, L.
Silvain, C.
Botta-Fridlund, D.
Leroy, V.
Bourliere, M.
D'alteroche, L.
Hubert-Fouchard, I.
Guyader, D.
Rosa, I.
Nguyen-Khac, E.
Di Martino, V.
Carrat, F.
Fedchuk, L.
Akremi, R.
Bennai, Y.
Bronowicki, J.
[J]. JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 29 - 29
[8] DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN FOR THE TREATMENT OF CHRONIC HCV INFECTION IN PATIENTS WITH DECOMPENSATED CIRRHOSIS: RESULTS OF A EUROPEAN MULTICENTRE COMPASSIONATE USE PROGRAM
Petersen, J.
Welzel, T.
Herzer, K.
Ferenci, P.
Gschwantler, M.
Cornberg, M.
Ingiliz, P.
Berg, T.
Spengler, U.
Weiland, O.
van der Valk, M.
Klinker, H.
Rockstroh, J.
Peck-Radosavljevic, M.
Zhao, Y.
Jimenez-Exposito, M. J.
Zeuzem, S.
[J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S781 - S782
[9] Safety and efficacy of daclatasvir plus sofosbuvir with or without ribavirin for the treatment of chronic HCV genotype 3 infection: Interim results of a multicenter European compassionate use program
Welzel, Tania M.
Petersen, Joerg
Ferenci, Peter
Gschwantler, Michael
Herzer, Kerstin
Cornberg, Markus
Schott, Eckart
Berg, Thomas
Spengler, Ulrich
Weiland, Ola
van der Valk, Marc
Geier, Andreas
Rockstroh, Juergen K.
Peck-Radosavljevic, Markus
Zhao, Yue
Exposito, Maria Jesus Jimenez
Zeuzem, Stefan
[J]. HEPATOLOGY, 2015, 62 : 225A - 226A
[10] Daclatasvir in combination with sofosbuvir with or without ribavirin is safe and efficacious in liver transplant recipients with HCV recurrence: Interim results of a multicenter compassionate use program
Herzer, Kerstin
Welzel, Tania M.
Ferenci, Peter
Petersen, Joerg
Gschwantler, Michael
Cornberg, Markus
Berg, Thomas
Spengler, Ulrich
Weiland, Ola
van der Valk, Marc
Klinker, Hartwig
Rockstroh, Juergen K.
Schott, Eckart
Peck-Radosavljevic, Markus
Zhao, Yue
Exposito, Maria Jesus Jimenez
Zeuzem, Stefan
[J]. HEPATOLOGY, 2015, 62 : 341A - 341A

← 1 2 3 4 5 →